Our people
Professor Lyn Griffiths
Professor Lyn Griffiths is the director of the Centre for Genomics and Personalised Health at QUT. Lyn has been studying the genes involved in common human disorders for many years, her expertise is in the field of human gene mapping and molecular genetics. Lyn established and heads the Genomics Research Centre at QUT where research focuses on identifying the genes involved in complex disorders, including migraine, CADASIL (hereditary stroke) and other neurogenetic disorders as well as concussion, memory and metabolic disorders. The NATA accredited laboratory also undertakes regular diagnostic testing for six human migraine related neurogenetic disorders. Lyn is a member of several medical advisory boards for industry and charitable foundations and is the director of the MTPconnect Bridge and BridgeTech commercialisation training programs.
Professor Derek Richard
Professor Derek Richard is a co-deputy director of the Centre for Genomics and Personalised Health. He is also the scientific director of the Cancer & Ageing Research Program (www.carp.org.au) and director of Drug Discovery Queensland at QUT. He leads a group of over 50 scientists and students, with interests in how cells prevent mutations in the genetic code, how mutations drive disease and in the development of therapeutics to target genetic diseases. His work has resulted in the formation of two biotechnology companies.
Professor Nathan Subramaniam
Professor Nathan Subramaniam is a co-deputy director of the Centre for Genomics and Personalised Health. He is an NHMRC Senior Research Fellow and professor of biomedical sciences (molecular medicine) in the School of Biomedical Sciences, Faculty of Health at QUT. Nathan heads the Hepatogenomics Research Group at QUT where research focuses on identifying and characterising genes involved in the development of liver and iron-related disease. The aim is to advance the understanding of these disorders at a molecular level with the ultimate objective of development of diagnostics and therapeutic interventions. His group has been instrumental in defining the genetic basis of many iron-related disorders.
